Field Cancerization Therapies: Medical Dermatology and Beyond

In this presentation, experts discuss field cancerization, a concept first identified in oropharyngeal carcinomas that describes the presence of atypical cells in otherwise healthy tissue, creating a predisposed field for tumor growth. They highlight the importance of recognizing the risk factors associated with field cancerization, including genetic predisposition, UV exposure, and immunosuppression, particularly in patients with fair skin and those with a history of skin cancers. The speakers address treatment strategies that include a variety of topical therapies, laser treatments, and photodynamic therapies, emphasizing the significance of combining therapies for improved efficacy and patient outcomes. A detailed management algorithm is presented, advising on the use of field therapies based on lesion density and patient history. Emphasis is placed on patient education regarding treatment tolerability and downtime, while highlighting new innovations such as DNA repair enzymes and advanced light therapy options. The effectiveness of combination treatments is shown through case examples, demonstrating significant improvement in patient conditions. The discussion concludes by reinforcing the complexity of managing field cancerization but underscores the potential for improved quality of life through tailored treatment options.